COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03747120
Brief Title: Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab

First Submitted : November 16, 2018
First Submitted that Met QC Criteria : November 16, 2018
First Posted : November 20, 2018

Last Update Submitted that Met QC Criteria : January 13, 2021
Last Update Posted : January 15, 2021 (Estimate)